Category Archives: Muscular Dystrophy Treatment

PALM BEACH, Fla., Aug. 26, 2020 /PRNewswire/ -- Although various market revenue projections may differ in the total dollar figures, the reports in the triple negative breast cancer (TNBC) treatment market all predict a sustainable growth oner the next several years to come. A previous report from Mind Aspire Market Research was trumped by another report from Future Wise Research Continue reading →

Letters to the Editor Aug 29, 2020 To the editor: They didnt give me the right to try experimental treatments, Mr. President. You did and without you, Id have died waiting for them to be approved, said Natalie Harp on Monday night at the Republican National Convention Continue reading →

- Integrated program encompasses formulation development, drug substances and drug product manufacturing - Project involves three Piramal Pharma Solutions (PPS) sites in India - New, specialized technologies have been added in a dedicated area MUMBAI, India, Aug. 27, 2020 /PRNewswire/ -- Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that the company will be partnering with Epirium Bio on an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with high unmet needs. The Piramal Pharma Solutions (PPS) team is providing Epirium with an integrated program that encompasses formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product. Continue reading →

The next 73 days are going to be very difficult for Stephen Hahn. As the Nov. 3 election nears, the Food and Drug Administration commissioner can expect intensifying pressure from President Trump to approve a vaccine or a drug to combat Covid-19. Continue reading →

For six decades, firefighters have been the boots on the ground at intersections across America to collect donations for the Muscular Dystropy Association. Continue reading →

Global Duchenne Muscular Dystrophy Treatment Market (2020) thoroughly scrutinizes the effects of a wide range of factors impacting the market drivers and development. Furthermore, it offers in-depth insights into the key producers, market outline, as well as conjecture and provincial investigation. This report also inspects the global Duchenne Muscular Dystrophy Treatment market wholesalers, deals channels, difficulties, openings, drivers, future patterns, development rate, market share, rivalry scene, and status Continue reading →

Muscular Dystrophy Treatment Market Report 2020-2026 incorporates a complete examination of the current market. Continue reading →

From Netdoctor Scoliosis is a curvature of the spine in which it twists and curves to the side. It can affect people of any age but most often starts during the growth spurt before puberty. Continue reading →

Dyne Therapeutics started out last April with a modest $50 million to mine targeted muscle disease therapies from its in-house conjugate technology. The biotech has now convinced more investors that its got gems on its hands, closing $115 million in fresh financing to push its next-gen oligonucleotide drugs into the clinic. Continue reading →

Map of FSHD Clinical Trial Research Network sites LEXINGTON, Mass. Continue reading →